LGND - Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q2 2021 Results - Earnings Call Transcript
Ligand Pharmaceuticals Incorporated (LGND) Q2 2021 Earnings Conference Call July 29, 2021 04:30 PM ET Company Participants Simon Latimer - Head of IR John Higgins - CEO Matthew Korenberg - CFO Matt Foehr - COO Matthew Foehr - Conference Call Participants Lawrence Solow - CJS Securities Matt Hewitt - Craig-Hallum Capital Balaji Prasad - Barclays Jacob Johnson - Stephens Scott Henry - ROTH Capital Presentation Operator Good day and thank you for standing by. Welcome to the Ligand Pharmaceuticals Second Quarter Earnings Call. At this time all participants are in a listen-only mode. After the speaker's presentation there will be a question and answer session. [Operator Instructions.] I would now like to hand the conference over to your first speaker today the Head of Investor Relations, Mr. Simon Latimer. Please go ahead sir. Simon Latimer Thank you. Welcome to Ligand's second quarter of 2021 financial results and business update conference
For further details see:
Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q2 2021 Results - Earnings Call Transcript